OMEPRAZOLE, SODIUM BICARBONATE and INCORRECT PRODUCT ADMINISTRATION DURATION

39 reports of this reaction

1.8% of all OMEPRAZOLE, SODIUM BICARBONATE reports

#10 most reported adverse reaction

Overview

INCORRECT PRODUCT ADMINISTRATION DURATION is the #10 most commonly reported adverse reaction for OMEPRAZOLE, SODIUM BICARBONATE, manufactured by CVS Pharmacy. There are 39 FDA adverse event reports linking OMEPRAZOLE, SODIUM BICARBONATE to INCORRECT PRODUCT ADMINISTRATION DURATION. This represents approximately 1.8% of all 2,134 adverse event reports for this drug.

Patients taking OMEPRAZOLE, SODIUM BICARBONATE who experience incorrect product administration duration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INCORRECT PRODUCT ADMINISTRATION DURATION39 of 2,134 reports

INCORRECT PRODUCT ADMINISTRATION DURATION is a less commonly reported adverse event for OMEPRAZOLE, SODIUM BICARBONATE, but still significant enough to appear in the safety profile.

Other Side Effects of OMEPRAZOLE, SODIUM BICARBONATE

In addition to incorrect product administration duration, the following adverse reactions have been reported for OMEPRAZOLE, SODIUM BICARBONATE:

Other Drugs Associated with INCORRECT PRODUCT ADMINISTRATION DURATION

The following drugs have also been linked to incorrect product administration duration in FDA adverse event reports:

DOCOSANOLETONOGESTRELGLYCERIN, LIDOCAINEGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDEINSTALAX POLYETHYLENE GLYCOL 3350LOPERAMIDE HCLLOPERAMIDE HYDROCHLORIDE ORALPOLYETHYLENE GLYCOL 3350POLYETHYLENE GLYCOL 400TASIMELTEON

Frequently Asked Questions

Does OMEPRAZOLE, SODIUM BICARBONATE cause INCORRECT PRODUCT ADMINISTRATION DURATION?

INCORRECT PRODUCT ADMINISTRATION DURATION has been reported as an adverse event in 39 FDA reports for OMEPRAZOLE, SODIUM BICARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INCORRECT PRODUCT ADMINISTRATION DURATION with OMEPRAZOLE, SODIUM BICARBONATE?

INCORRECT PRODUCT ADMINISTRATION DURATION accounts for approximately 1.8% of all adverse event reports for OMEPRAZOLE, SODIUM BICARBONATE, making it a notable side effect.

What should I do if I experience INCORRECT PRODUCT ADMINISTRATION DURATION while taking OMEPRAZOLE, SODIUM BICARBONATE?

If you experience incorrect product administration duration while taking OMEPRAZOLE, SODIUM BICARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

OMEPRAZOLE, SODIUM BICARBONATE Full ProfileAll Drugs Causing INCORRECT PRODUCT ADMINISTRATION DURATIONCVS Pharmacy Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.